Education
About Us
Working with TipRanks
Follow Us
David Lebwohl Insider Profile
4 Followers
David Lebwohl, EVP, Chief Medical Officer at Intellia Therapeutics, holds 87.67K shares in Intellia Therapeutics (Ticker: NTLA). Most recently, David Lebwohl Sold $9,557 shares of Intellia Therapeutics on Jan 07, 2025 for an estimated value of 116.40K.
David Lebwohl Intellia Therapeutics (NTLA)EVP, Chief Medical Officer
Intellia Therapeutics (NTLA)
EVP, Chief Medical Officer
Ranked #21,202 out of 100,956 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+33.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP, Chief Medical Officer
Roles that David Lebwohl holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 05, 2024 - Jan 05, 2025
Return:+57.60%
The most profitable trade made by David Lebwohl
David Lebwohl's Trading History
List of latest transactions for each holding click on a transaction to see David Lebwohl's performance on stock
You May Also Like
David Lebwohl insider profile FAQ
What is the percentage of profitable transactions made by David Lebwohl?
The percentage of profitable transactions made by David Lebwohl is 100%.
What is the average return per transaction made by David Lebwohl?
The average return per transaction made by David Lebwohl is 33.10%.
What stocks does David Lebwohl hold?
David Lebwohl holds: NTLA stocks.
What was David Lebwohl’s latest transaction?
David Lebwohl latest transaction was an Informative Sell of $116.40K.
What was David Lebwohl's most profitable transaction?
David Lebwohl’s most profitable transaction was an Informative Sell of NTLA stock on January 5, 2024. The return on the trade was 57.60%.
What is David Lebwohl's role in Intellia Therapeutics?
David Lebwohl's role in Intellia Therapeutics is EVP, Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.